An observational study in Pain and Opioid Induced Constipation, sponsored by Mundipharma AB. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-08-07.
Sponsored by Mundipharma AB · Observational
The objective of the non-interventional study is to compare the quality of life, health care resource use and costs between the use of a combination of oxycodone and naloxone (Targiniq) versus oxycodone and laxatives for patients with severe pain, and to evaluate the cost-effectiveness of treatment with Targiniq.
2,450 studies on the registry are indexed under Pain; 945 are open to participants now.
This study's enrollment of 37 is below the median of 100 across 301 observational studies indexed under Pain.
Browse Pain studies →Mundipharma AB is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
The patients have severe pain treated with opioids and will be enrolled at different clinics in Sweden
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Quality of Life
Two visits performed over 8 weeks
Time frame: 8 Weeks
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.